Publications

Armstrong-Hough M, Turimumahoro P, Meyer AJ, Ochom E, Babirye D, Ayakaka I, Mark D, Ggita J, Cattamanchi A, Dowdy D, Mugabe F, Fair E, Haberer JE, Katamba A, Davis JL. Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study. PLoS One. 2017 Nov 6;12(11):e0187145. doi: 10.1371/journal.pone.0187145. PMID: 29108007; PMCID: PMC5673209.

Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, Fair E, Hopewell P, Handley MA, Cattamanchi A, Katamba A, Davis JL. Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach. Implement Sci. 2017 Mar 9;12(1):33. doi: 10.1186/s13012-017-0561-4. PMID: 28274245; PMCID: PMC5343292.

Bahrainwala L, Knoblauch AM, Andriamiadanarivo A, Diab MM, McKinney J, Small PM, Kahn JG, Fair E, Rakotosamimanana N, Grandjean Lapierre S. Drones and digital adherence monitoring for community-based tuberculosis control in remote Madagascar: A cost-effectiveness analysis. PLoS One. 2020 Jul 7;15(7):e0235572. doi: 10.1371/journal.pone.0235572. PMID: 32634140; PMCID: PMC7340291.

Bisimwa BC, Nachega JB, Warren RM, Theron G, Metcalfe JZ, Shah M, Diacon AH, Sam-Agudu NA, Yotebieng M, Bulabula ANH, Katoto PDMC, Chirambiza JP, Nyota R, Birembano FM, Musafiri EM, Byadunia S, Bahizire E, Kaswa MK, Callens S, Kashongwe ZM. Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications. Clin Infect Dis. 2021 Jul 15;73(2):e362-e370. doi: 10.1093/cid/ciaa873. PMID: 32590841; PMCID: PMC8282324.

Blount RJ, Phan H, Trinh T, Dang H, Merrifield C, Zavala M, Zabner J, Comellas AP, Stapleton EM, Segal MR, Balmes J, Nhung NV, Nahid P. Indoor Air Pollution and Susceptibility to Tuberculosis Infection in Urban Vietnamese Children. Am J Respir Crit Care Med. 2021 Nov 15;204(10):1211-1221. doi: 10.1164/rccm.202101-0136OC. PMID: 34343025.

Cattamanchi A, Crowder R, Kityamuwesi A, Kiwanuka N, Lamunu M, Namale C, Tinka LK, Nakate AS, Ggita J, Turimumahoro P, Babirye D, Oyuku D, Berger C, Tucker A, Patel D, Sammann A, Turyahabwe S, Dowdy D, Katamba A. Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda. PLoS Med. 2021 May 6;18(5):e1003628. doi: 10.1371/journal.pmed.1003628. PMID: 33956802; PMCID: PMC8136841.

Chitnis AS, Jaganath D, Gish RG, Wong RJ. Diagnosis and Treatment of Latent Tuberculosis Infection. Am J Gastroenterol. 2021 Nov 1;116(11):2155-2158. doi: 10.14309/ajg.0000000000001398. PMID: 34382949.

Connelly JT, Andama A, Grant BD, Ball A, Mwebe S, Asege L, Nakaye M, Lopez BB, Hsieh HV, Katumba D, Mukwatamundu J, Nalubega M, Hunt VM, Burkot S, Ramachandraiah H, Choudhary A, Ignatowicz L, Weigl BH, Bachman C, Mulondo J, Semitala F, Worodria W, Pinter A, Hamasur B, Bell D, Cattamanchi A, Somoskovi A. Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients. PLoS One. 2021 Jul 26;16(7):e0254156. doi: 10.1371/journal.pone.0254156. PMID: 34310609; PMCID: PMC8312950.

Dorman SE, Nahid P, Kurbatova EV, Phillips PPJ, Bryant K, Dooley KE, Engle M, Goldberg SV, Phan HTT, Hakim J, Johnson JL, Lourens M, Martinson NA, Muzanyi G, Narunsky K, Nerette S, Nguyen NV, Pham TH, Pierre S, Purfield AE, Samaneka W, Savic RM, Sanne I, Scott NA, Shenje J, Sizemore E, Vernon A, Waja Z, Weiner M, Swindells S, Chaisson RE; AIDS Clinical Trials Group; Tuberculosis Trials Consortium. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 May 6;384(18):1705-1718. doi: 10.1056/NEJMoa2033400. PMID: 33951360; PMCID: PMC8282329.

Ernest JP, Strydom N, Wang Q, Zhang N, Nuermberger E, Dartois V, Savic RM. Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis. Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:495-516. doi: 10.1146/annurev-pharmtox-030920-011143. Epub 2020 Aug 17. PMID: 32806997; PMCID: PMC7790895.

Fair E, Hopewell PC, Pai M. International Standards for Tuberculosis Care: revisiting the cornerstones of tuberculosis care and control. Expert Rev Anti Infect Ther. 2007 Feb;5(1):61-5. doi: 10.1586/14787210.5.1.61. PMID: 17266454.

Feng PJ, Wu Y, Ho CS, Chinna L, Whelen AC, Largen A, Brostrom R, Reves R, Belknap R, Cattamanchi A, Banaei N. Impact of T-Cell Xtend on T-SPOT.TB Assay in High-Risk Individuals after Delayed Blood Sample Processing. J Clin Microbiol. 2021 Apr 20;59(5):e00120-21. doi: 10.1128/JCM.00120-21. PMID: 33658266; PMCID: PMC8091829.

Guglielmetti L, Ardizzoni E, Atger M, Baudin E, Berikova E, Bonnet M, Chang E, Cloez S, Coit JM, Cox V, de Jong BC, Delifer C, Do JM, Tozzi DDS, Ducher V, Ferlazzo G, Gouillou M, Khan A, Khan U, Lachenal N, LaHood AN, Lecca L, Mazmanian M, McIlleron H, Moschioni M, O'Brien K, Okunbor O, Oyewusi L, Panda S, Patil SB, Phillips PPJ, Pichon L, Rupasinghe P, Rich ML, Saluhuddin N, Seung KJ, Tamirat M, Trippa L, Cellamare M, Velásquez GE, Wasserman S, Zimetbaum PJ, Varaine F, Mitnick CD. Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial. Trials. 2021 Sep 25;22(1):651. PMID: 34563240; PMCID: PMC8465691. 

Hopewell PC, Fair EL, Uplekar M. Updating the International Standards for Tuberculosis Care. Entering the era of molecular diagnostics. Ann Am Thorac Soc. 2014 Mar;11(3):277-85. doi: 10.1513/AnnalsATS.201401-004AR. PMID: 24673691.

Hopewell PC, Reichman LB, Castro KG. Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and Control. Emerg Infect Dis. 2021 Mar;27(3):681-686. doi: 10.3201/eid2703.203456. Epub 2020 Nov 19. PMID: 33213689; PMCID: PMC7920655.

Huddart S, Savic RM, Cattamanchi A. Is Glycemic Control the Secret to Tuberculosis Control? Am J Respir Crit Care Med. 2021 Aug 1;204(3):254-255. doi: 10.1164/rccm.202103-0703ED. PMID: 33826869; PMCID: PMC8513585.

Hudson M, Rutherford GW, Weiser S, Fair E. Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review. PLoS One. 2018 Apr 10;13(4):e0194960. doi: 10.1371/journal.pone.0194960. PMID: 29634772; PMCID: PMC5892869.

Imperial MZ, Phillips PPJ, Nahid P, Savic RM. Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials. Am J Respir Crit Care Med. 2021 Nov 1;204(9):1086-1096. doi: 10.1164/rccm.202101-0117OC. PMID: 34346856; PMCID: PMC8663006.

Jaganath D, Wambi P, Reza TF, Nakafeero J, Aben EO, Kiconco E, Nannyonga G, Nsereko M, Sekadde MP, Mudiope M, Kato-Maeda M, Starke J, Andama A, Mohanty S, Wobudeya E, Cattamanchi A. A Prospective Evaluation of Xpert MTB/RIF Ultra for Childhood Pulmonary Tuberculosis in Uganda. J Pediatric Infect Dis Soc. 2021 May 28;10(5):586-592. doi: 10.1093/jpids/piaa159. PMID: 33416072; PMCID: PMC8163061.

Jarsberg LG, Kedia K, Wendler J, Wright AT, Piehowski PD, Gritsenko MA, Shi T, Lewinsohn DM, Sigal GB, Weiner MH, Smith RD, Keane J, Jacobs JM, Nahid P. Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region. PLoS One. 2021 May 5;16(5):e0250586. doi: 10.1371/journal.pone.0250586. PMID: 33951066; PMCID: PMC8099102.

Kadota JL, Nabwire S, Nalugwa T, White JS, Cattamanchi A, Katamba A, Shete PB. Patient Perspectives and Willingness to Accept Incentives for Tuberculosis Diagnostic Evaluation in Uganda. Value Health Reg Issues. 2021 Sep;25:48-56. doi: 10.1016/j.vhri.2020.12.005. Epub 2021 Mar 25. PMID: 33773327; PMCID: PMC8434939.

Kendall EA, Kitonsa PJ, Nalutaaya A, Erisa KC, Mukiibi J, Nakasolya O, Isooba D, Baik Y, Robsky KO, Kato-Maeda M, Cattamanchi A, Katamba A, Dowdy DW. The Spectrum of Tuberculosis Disease in an Urban Ugandan Community and Its Health Facilities. Clin Infect Dis. 2021 Jun 15;72(12):e1035-e1043. doi: 10.1093/cid/ciaa1824. PMID: 33283227; PMCID: PMC8204779.

Kerkhoff AD, Cattamanchi A, Muyoyeta M, Denkinger CM, Dowdy DW. Validating novel diagnostic assays for tuberculosis in the context of existing tools. Lancet Glob Health. 2021 Sep;9(9):e1209. doi: 10.1016/S2214-109X(21)00306-5. PMID: 34416206.

Kerkhoff AD, Havlir DV. CROI 2021: Tuberculosis, Opportunistic Infections, and COVID-19 Among People with HIV. Top Antivir Med. 2021 Apr-May;29(2):344-351. PMID: 34107204; PMCID: PMC8224244.

Kerkhoff AD, Kagujje M, Nyangu S, Mateyo K, Sanjase N, Chilukutu L, Eshun-Wilson I, Geng EH, Havlir DV, Muyoyeta M. Pathways to care and preferences for improving tuberculosis services among tuberculosis patients in Zambia: A discrete choice experiment. PLoS One. 2021 Aug 31;16(8):e0252095. doi: 10.1371/journal.pone.0252095. PMID: 34464392; PMCID: PMC8407587.

Lim RK, Semitala FC, Atuhumuza E, Sabiti L, Namakula-Katende J, Muyindike WR, Kamya MR, Dowdy D, Cattamanchi A. Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda. PLoS One. 2021 Feb 4;16(2):e0246113. doi: 10.1371/journal.pone.0246113. PMID: 33539400; PMCID: PMC7861427.

Lodi S, Emenyonu NI, Marson K, Kwarisiima D, Fatch R, McDonell MG, Cheng DM, Thirumurthy H, Gandhi M, Camlin CS, Muyindike WR, Hahn JA, Chamie G. The Drinkers' Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial. Trials. 2021 May 20;22(1):355. doi: 10.1186/s13063-021-05304-7. PMID: 34016158; PMCID: PMC8136096.

Louie JK, Agraz-Lara R, Romo L, Crespin F, Chen L, Graves S. Tuberculosis-Associated Hospitalizations and Deaths after COVID-19 Shelter-In-Place, San Francisco, California, USA. Emerg Infect Dis. 2021 Aug;27(8):2227-2229. doi: 10.3201/eid2708.210670. PMID: 34287142; PMCID: PMC8314834.

Mbelele PM, Mpolya EA, Sauli E, Mtafya B, Ntinginya NE, Addo KK, Kreppel K, Mfinanga S, Phillips PPJ, Gillespie SH, Heysell SK, Sabiiti W, Mpagama SG. Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania. J Clin Microbiol. 2021 Mar 19;59(4):e02927-20. doi: 10.1128/JCM.02927-20. PMID: 33536294; PMCID: PMC8092737.

McLaughlin TA, Nizam A, Hayara FO, Ouma GS, Campbell A, Khayumbi J, Ongalo J, Ouma SG, Shah NS, Altman JD, Kaushal D, Rengarajan J, Ernst JD, Blumberg HM, Waller LA, Gandhi NR, Day CL, Benkeser D. Schistosoma mansoni Infection Is Associated With a Higher Probability of Tuberculosis Disease in HIV-Infected Adults in Kenya. J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):157-163. doi: 10.1097/QAI.0000000000002536. PMID: 33074856; PMCID: PMC8284023.

Metcalfe J, Bacchetti P, Esmail A, Reckers A, Aguilar D, Wen A, Huo S, Muyindike WR, Hahn JA, Dheda K, Gandhi M, Gerona R. Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care setting. BMC Infect Dis. 2021 Jan 22;21(1):99. doi: 10.1186/s12879-020-05738-5. PMID: 33482745; PMCID: PMC7821664.

Mirzazadeh A, Kahn JG, Haddad MB, Hill AN, Marks SM, Readhead A, Barry PM, Flood J, Mermin JH, Shete PB. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity. PLoS One. 2021 Apr 1;16(4):e0249012. doi: 10.1371/journal.pone.0249012. PMID: 33793612; PMCID: PMC8016318.

Mwebe SZ, Yoon C, Asege L, Nakaye M, Katende J, Andama A, Cattamanchi A, Semitala FC. Impact of hematocrit on point-of-care C-reactive protein-based tuberculosis screening among people living with HIV initiating antiretroviral therapy in Uganda. Diagn Microbiol Infect Dis. 2021 Mar;99(3):115281. doi: 10.1016/j.diagmicrobio.2020.115281. Epub 2020 Nov 26. PMID: 33453673.

Nabity SA, Han E, Lowenthal P, Henry H, Okoye N, Chakrabarty M, Chitnis AS, Kadakia A, Villarino E, Low J, Higashi J, Barry PM, Jain S, Flood J. Sociodemographic Characteristics, Comorbidities, and Mortality Among Persons Diagnosed With Tuberculosis and COVID-19 in Close Succession in California, 2020. JAMA Netw Open. 2021 Dec 1;4(12):e2136853. doi: 10.1001/jamanetworkopen.2021.36853. PMID: 34860244; PMCID: PMC8642782.

Nathan A, Beynor JI, Baglaenko Y, Suliman S, Ishigaki K, Asgari S, Huang CC, Luo Y, Zhang Z, Lopez K, Lindestam Arlehamn CS, Ernst JD, Jimenez J, Calderón RI, Lecca L, Van Rhijn I, Moody DB, Murray MB, Raychaudhuri S. Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease. Nat Immunol. 2021 Jun;22(6):781-793. doi: 10.1038/s41590-021-00933-1. Epub 2021 May 24. PMID: 34031617; PMCID: PMC8162307.

Ordonez AA, Tucker EW, Anderson CJ, Carter CL, Ganatra S, Kaushal D, Kramnik I, Lin PL, Madigan CA, Mendez S, Rao J, Savic RM, Tobin DM, Walzl G, Wilkinson RJ, Lacourciere KA, Via LE, Jain SK. Visualizing the dynamics of tuberculosis pathology using molecular imaging. J Clin Invest. 2021 Mar 1;131(5):e145107. doi: 10.1172/JCI145107. PMID: 33645551; PMCID: PMC7919721.

Pettit AC, Stout JE, Belknap R, Benson CA, Séraphin MN, Lauzardo M, Horne DJ, Garfein RS, Maruri F, Ho CS; Tuberculosis Epidemiologic Studies Consortium (TBESC). Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2021 Oct 5;73(7):e2278-e2284. doi: 10.1093/cid/ciaa1135. PMID: 32761083.

Puryear SB, Fatch R, Beesiga B, Kekibiina A, Lodi S, Marson K, Emenyonu NI, Muyindike WR, Kwarisiima D, Hahn JA, Chamie G. Higher Levels of Alcohol Use Are Associated With Latent Tuberculosis Infection in Adults Living With Human Immunodeficiency Virus. Clin Infect Dis. 2021 Mar 1;72(5):865-868. doi: 10.1093/cid/ciaa527. PMID: 32374867; PMCID: PMC7935375.

Quinn CM, Kagimu E, Okirworth M, Bangdiwala AS, Mugumya G, Ramachandran PS, Wilson MR, Meya DB, Cresswell FV, Bahr NC, Boulware DR. Fujifilm SILVAMP TB LAM Assay on Cerebrospinal Fluid for the Detection of Tuberculous Meningitis in Adults With Human Immunodeficiency Virus. Clin Infect Dis. 2021 Nov 2;73(9):e3428-e3434. doi: 10.1093/cid/ciaa1910. PMID: 33388751; PMCID: PMC8563225.

Radtke KK, Ernest JP, Zhang N, Ammerman NC, Nuermberger E, Belknap R, Boyd R, Sterling TR, Savic RM. Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study. Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0170521. doi: 10.1128/AAC.01705-21. Epub 2021 Oct 4. PMID: 34606336; PMCID: PMC8597776.

Radtke KK, Hibma JE, Hesseling AC, Savic RM. Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children. Eur Respir J. 2021 Jan 5;57(1):2001756. doi: 10.1183/13993003.01756-2020. PMID: 32703775; PMCID: PMC7870317.

Samuels THA, Shete PB, Ojok C, Nalugwa T, Farr K, Turyahabwe S, Katamba A, Cattamanchi A, Moore DAJ. Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda. PLoS One. 2021 Jul 16;16(7):e0253927. doi: 10.1371/journal.pone.0253927. PMID: 34270582; PMCID: PMC8284677.

Silva S, Arinaminpathy N, Atun R, Goosby E, Reid M. Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis. Lancet Glob Health. 2021 Oct;9(10):e1372-e1379. doi: 10.1016/S2214-109X(21)00299-0. Epub 2021 Sep 3. Erratum in: Lancet Glob Health. 2021 Nov;9(11):e1507. PMID: 34487685; PMCID: PMC8415897.

Tadokera R, Huo S, Theron G, Timire C, Manyau-Makumbirofa S, Metcalfe JZ. Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study. PLoS One. 2021 Jul 16;16(7):e0254204. doi: 10.1371/journal.pone.0254204. PMID: 34270593; PMCID: PMC8284678.

Te Brake LHM, de Jager V, Narunsky K, Vanker N, Svensson EM, Phillips PPJ, Gillespie SH, Heinrich N, Hoelscher M, Dawson R, Diacon AH, Aarnoutse RE, Boeree MJ; PanACEA Consortium. Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg^-1 rifampicin. Eur Respir J. 2021 Jul 8;58(1):2000955. doi: 10.1183/13993003.00955-2020. PMID: 33542056; PMCID: PMC8411896.

Vasquez: Robertson GT, Ramey ME, Massoudi LM, Carter CL, Zimmerman M, Kaya F, Graham BG, Gruppo V, Hastings C, Woolhiser LK, Scott DWL, Asay BC, Eshun-Wilson F, Maidj E, Podell BK, Vásquez JJ, Lyons MA, Dartois V, Lenaerts AJ. Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0058321. doi: 10.1128/AAC.00583-21. Epub 2021 Aug 9. PMID: 34370580; PMCID: PMC8522729.

Velleca M, Malekinejad M, Miller C, Abascal Miguel L, Reeves H, Hopewell P, Fair E. The yield of tuberculosis contact investigation in low- and middle-income settings: a systematic review and meta-analysis. BMC Infect Dis. 2021 Sep 27;21(1):1011. doi: 10.1186/s12879-021-06609-3. PMID: 34579667; PMCID: PMC8474777.

Walter ND, Born SEM, Robertson GT, Reichlen M, Dide-Agossou C, Ektnitphong VA, Rossmassler K, Ramey ME, Bauman AA, Ozols V, Bearrows SC, Schoolnik G, Dolganov G, Garcia B, Musisi E, Worodria W, Huang L, Davis JL, Nguyen NV, Nguyen HV, Nguyen ATV, Phan H, Wilusz C, Podell BK, Sanoussi ND, de Jong BC, Merle CS, Affolabi D, McIlleron H, Garcia-Cremades M, Maidji E, Eshun-Wilson F, Aguilar-Rodriguez B, Karthikeyan D, Mdluli K, Bansbach C, Lenaerts AJ, Savic RM, Nahid P, Vásquez JJ, Voskuil MI. Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens. Nat Commun. 2021 May 18;12(1):2899. doi: 10.1038/s41467-021-22833-6. PMID: 34006838; PMCID: PMC8131613.

Watson A, Li H, Ma B, Weiss R, Bendayan D, Abramovitz L, Ben-Shalom N, Mor M, Pinko E, Bar Oz M, Wang Z, Du F, Lu Y, Rybniker J, Dahan R, Huang H, Barkan D, Xiang Y, Javid B, Freund NT. Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis. Nat Commun. 2021 Jan 27;12(1):602. doi: 10.1038/s41467-021-20930-0. PMID: 33504803; PMCID: PMC7840946.

Weiner M, Gelfond J, Johnson-Pais TL, Engle M, Johnson JL, Whitworth WC, Bliven-Sizemore E, Nsubuga P, Dorman SE, Savic R; Pharmacokinetics/Pharmacodynamics Group of Tuberculosis Trials Consortium. Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis. J Antimicrob Chemother. 2021 Feb 11;76(3):582-586. doi: 10.1093/jac/dkaa490. PMID: 33374006; PMCID: PMC7879139.

Wood RC, Andama A, Hermansky G, Burkot S, Asege L, Job M, Katumba D, Nakaye M, Mwebe SZ, Mulondo J, Bachman CM, Nichols KP, Le Ny AM, Ortega C, Olson RN, Weigel KM, Olson AM, Madan D, Bell D, Cattamanchi A, Worodria W, Semitala FC, Somoskovi A, Cangelosi GA, Minch KJ. Characterization of oral swab samples for diagnosis of pulmonary tuberculosis. PLoS One. 2021 May 17;16(5):e0251422. doi: 10.1371/journal.pone.0251422. PMID: 33999938; PMCID: PMC8128230.

Zhang N, Savic RM, Boeree MJ, Peloquin CA, Weiner M, Heinrich N, Bliven-Sizemore E, Phillips PPJ, Hoelscher M, Whitworth W, Morlock G, Posey J, Stout JE, Mac Kenzie W, Aarnoutse R, Dooley KE; Tuberculosis Trials Consortium (TBTC) and Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA) Networks. Optimising pyrazinamide for the treatment of tuberculosis. Eur Respir J. 2021 Jul 20;58(1):2002013. doi: 10.1183/13993003.02013-2020. PMID: 33542052; PMCID: PMC8371453.